Arca Biopharma Inc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
ABIO Nasdaq 2834 http://arcabio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arca Biopharma Inc

ARCA Biopharma Announces Third Quarter 2019 Financial Results and Provides Corporate Update - Nov 6th, 2019 9:10 pm
Is ARCA biopharma (NASDAQ:ABIO) In A Good Position To Invest In Growth? - Nov 3rd, 2019 1:47 pm
ARCA Biopharma President and CEO Dr. Michael Bristow to Present at HFSA 2019 Excellence in Translational Science Symposium - Sep 12th, 2019 12:30 pm
Arca Biopharma Announces Gencaro Atrial Fibrillation Clinical Data Selected for Presentation at HFSA 2019 Scientific Meeting - Sep 11th, 2019 12:30 pm
Could The ARCA biopharma, Inc. (NASDAQ:ABIO) Ownership Structure Tell Us Something Useful? - Sep 4th, 2019 5:37 pm
ARCA biopharma Announces Second Quarter 2019 Financial Results and Provides Corporate Update - Aug 1st, 2019 8:30 pm
One Thing To Remember About The ARCA biopharma, Inc. (NASDAQ:ABIO) Share Price - Jun 4th, 2019 11:09 am
ARCA biopharma Announces Submission of Patent Application to U.S. Patent and Trademark Office Covering Treatment of Atrial Fibrillation in Patients With Heart Failure - May 13th, 2019 1:00 pm
ARCA Biopharma Announces First Quarter 2019 Financial Results and Provides Corporate Update - May 8th, 2019 8:30 pm
GENETIC-AF Phase 2B Trial Results Published in the Journal of American College of Cardiology: Heart Failure - May 1st, 2019 12:30 pm
ARCA biopharma Announces Steering Committee of Leading International Cardiology and Electrophysiology Experts for PRECISION-AF Phase 3 Clinical Trial - Apr 23rd, 2019 12:30 pm
Identification of Phosphodiesterease 3A Polymorphism With Potential to Increase Effectiveness of PDE3 Inhibitors Published in the Journal of the American College of Cardiology - Mar 18th, 2019 12:30 pm
Dose Response of Beta-Blockers in Adrenergic Receptor Polymorphism Genotypes Paper Published in Circulation: Genomic and Precision Medicine - Mar 6th, 2019 1:00 pm
ARCA biopharma Announces Fiscal Year 2018 Financial Results and Provides Corporate Update - Feb 27th, 2019 9:15 pm
ARCA Biopharma Announces FDA Agreement for a Single Phase 3 Clinical Trial to Support Approval for the First Genetically-Targeted Cardiovascular Drug - Feb 20th, 2019 12:30 pm
Zosano Appoints Linda Grais M.D., J.D. to Board of Directors - Jan 16th, 2019 1:30 pm
ARCA biopharma, Inc. (NASDAQ:ABIO) Insiders Have Been Selling - Dec 26th, 2018 4:47 pm
ARCA biopharma Updates Special Protocol Assessment Request to FDA for Gencaro Phase 3 Atrial Fibrillation Clinical Trial - Dec 20th, 2018 9:01 pm